Rubenslash
Member
Boehringer Ingelheim as wellAcousia, Frequency, Audion and Decibel or Sound Pharma ?
https://www.boehringer-ingelheim.co...collaboration-develop-hearing-loss-treatments
Boehringer Ingelheim as wellAcousia, Frequency, Audion and Decibel or Sound Pharma ?
Acousia work together with Boeringer Ingelheim. Acousia has people with lonh expertise in hair cell research.Boehringer Ingelheim as well
https://www.boehringer-ingelheim.co...collaboration-develop-hearing-loss-treatments
I think Otologic Pharmaceuticals only has potential treatments that can be used in the acute phase after acoustic trauma. It would not useful for the vast majority of us on this forum.Acousia work together with Boeringer Ingelheim. Acousia has people with lonh expertise in hair cell research.
It's promising that there is movement in the field...As far I know, Hough Ear / Otologic Pharma will also preparing for tests in 2017.
I think Otologic Pharmaceuticals only has potential treatments that can be used in the acute phase after acoustic trauma. It would not useful for the vast majority of us on this forum.
I'm like a 25 minute drive from all those companies. Maybe it's time to network with someone from those places...I didn't know about Audion
Strange things though is that Audion, Decibel TX and Frequency TX all involves in their core members scientists from Harvard Medical School and Massachusetts Eye and Ear Hospital.
It's strange that's they are starting différents companies... I hope they are not fooling us
Not a bad idea. It would be great to get updates from them to see how far out we are really looking at before clinical trials can begin.I'm like a 25 minute drive from all those companies. Maybe it's time to network with someone from those places...
You're right there's no evidence that regenerated hair cells would supress Tinnitus together with improved hearing. That's why my hopes are rather related to repair of demaged nerve fibers connections to hair cells through delivery of growth factors ie. NT3), I trust Liberman and Decibel theory that it's synaptic demage that causes TI hope the first treatment that comes does not include drilling of a hole in the cochlea.
But there is no research to suggest that the establishment of hearing cells could help T ?
Is NT3 the protein Decibel Therapeutics works with
Yes exactly, but as far as I know they're still like 2 years before to begin clinical trial. Currently they work on diagnostic platform for cochlear synaptopathy
I read somewhere that it takes months to years for SGN's to retract back from its corresponding haircell,not sure how accurate that is but just food for thought.And they have no clue yet about the "window of opportunity" regarding NT3.
Unfortunately this may be too late for us. As @Foncky stated there will be a therapeutic window but they don't know yet how long, I'm affraid 5 years might be too long so I rather plan to sign up for clinical trials to gain the timeThank you very much for your answer
I just hopes der will be a solution within 5 years
There was a study done on mice that saw SGNs deteriorate after just a year, but in humans we see people who have been completely deaf and receive cochlear implants, giving them the ability to hear again after >17 years. The jury is still out on the exact window, but real world evidence tells us it isn't crazy to think it's in the magnitude of years. Probably sooner the better, but even then we'll just have to find a way to regenerate the SGNs,I read somewhere that it takes months to years for SGN's to retract back from its corresponding haircell,not sure how accurate that is but just food for thought.
The first person on TT to say stem cells worked for them, I'm going to get it done.
But if stem cells really works, there is probably no reason to worry? it's probably just waiting for one of the big firms enter the field, it is not what Frequency Therapeutics is working with?
Therapy base on stem cells and regenerative médecine are now eligible to a new FDA path that will accelerate their availability for patients in the US :
http://www.sciencemag.org/news/2016...-cell-advocates-expect-regulatory-shortcuts-0
According to the article in the fist version of the law they wanted to make the therapy available to patients as soon as those therapies passed the safety test in clinical trials. Too bad they had to change it to make it pass, but it's something at least
The problem is that most of these companies are not even in phase I... some aren't even in preclinical.Berlin based company AudioCure raises 9 Mio for research.
http://www.finsmes.com/2016/11/audiocure-pharma-raises-e9m-in-funding.html
So at the moment we have a bigger familiy in companies targeting hearing loss and tinnitus
Audion Therapeutics (Netherlands)
Audio Cure (Germany)
Acousia Therapeutics (Germany)
Böhringer Ingelheim (Germany)
Sensorion Pharma (France)
Soundpharmaceuticals (USA)
Decibel Therapeutics (USA)
Frequency Therapeutics (USA)
Otologic Pharma (Oklahoma USA)
Affichem SA (France)
Otonomy (USA)
Auris Medical (Switzerland)
Novartis (Switzerland)
Roche (Inception3) (Switzerland)
Quark Pharma (USA)
Amazing, 20 years ago there was just one company called Otogene with their regenerative discovery.
This discovery has been further developed by Soundpharmaceuticals and the co fouunder of Otogene now founded Acousia.